HIT
Health In Tech, Inc.
HIT lost money over the past year, so it has no meaningful PE right now.
HIT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Strong |
HIT's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are weak.
HIT PE Valuation
HIT has no meaningful PE right now: it lost money over the past year.
HIT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect HIT's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.
HIT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.07 | -450% |
| Q1 2026 | -$0.02 | -200% |
| Q4 2025 | $0.02 | +100% |
| Q3 2025 | $0.03 | 0% |
| Q2 2025 | $0.02 | -33% |
| Q1 2025 | $0.02 | -33% |
| Q4 2024 | $0.01 | -80% |
HIT has swung to a loss: it lost $0.07 per share over the past year, after a profit the year before.
HIT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.1M | -13% |
| Q1 2026 | $8.8M | +9.4% |
| Q4 2025 | $7.5M | +53% |
| Q3 2025 | $8.5M | +90% |
| Q2 2025 | $9.3M | +86% |
| Q1 2025 | $8M | +56% |
| Q4 2024 | $4.9M | -6% |
| Q3 2024 | $4.5M | -15% |
HIT's revenue is growing: $8M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -41% | -50 points |
| Q1 2026 | -24% | -32 points |
| Q4 2025 | -5.9% | +0.5 points |
| Q3 2025 | 7.1% | -2.8 points |
| Q2 2025 | 8.9% | -1.7 points |
| Q1 2025 | 8.5% | +2 points |
| Q4 2024 | -6.5% | -34 points |
| Q3 2024 | 9.8% | -0.1 points |
HIT's operating margin was −41% last quarter, down 50 points from the same quarter a year ago, near the bottom of its range since 2023.
HIT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9M | -297% |
| Q1 2026 | -$3.3M | -729% |
| Q4 2025 | $451.2K | +$1.6M |
| Q3 2025 | $674K | -67% |
| Q2 2025 | $1.5M | +26% |
| Q1 2025 | $527.4K | +$1.3M |
| Q4 2024 | -$1.1M | -$454.1K |
| Q3 2024 | $2.1M | +509% |
HIT's free cash flow was −$5M over the past year, against $3M the year before.
HIT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -115.4x | Net Cash |
| Q4 2025 | -3.0x | Net Cash |
| Q3 2025 | -3.1x | Net Cash |
| Q2 2025 | -3.2x | Net Cash |
| Q1 2025 | -3.4x | Net Cash |
| Q4 2024 | -4.0x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
| Q2 2024 | 0.0x | Very low |
HIT has more cash than debt.
HIT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.1 | Oversold |
| Stochastic | 9.3 | Oversold |
HIT's weekly RSI is 27 (oversold) and its Stochastic is 9 (oversold).
HIT PE vs Technology Sector
| Metric | HIT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
HIT has no meaningful PE right now: it lost money over the past year.
HIT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.66 | 18% below |
| 20 week MA | $0.87 | 38% below |
| 50 week MA | $1.15 | 53% below |
HIT is in a downtrend: it's below all three of its weekly moving averages, and 53% below its 50-week average.
HIT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $5.46 | $5.46 | 0% |
| 2025 | $5.46 | $1.53 | -72% |
| 2026 YTD | $1.53 | $0.54 | -65% |
HIT has finished every year since 2024 lower, and it's down 65% so far in 2026.